EGFR testing: Best practice for NSCLC patients with exon 20 insertions
EGFR testing: Best practice for NSCLC patients with exon 20 insertions
Real-world evidence on PET use in Hodgkin lymphoma: An Argentinian perspective
An AI-derived digital pathology-based biomarker to predict the benefit of ADT in PC with validation in NRG/RTOG 9408
Survival outcomes of unilateral RB based on pathological risk stratification-experience at a tertiary care centre in Pakistan
SG in combination with pembro in patients with mUC who progressed after platinum (PLT)-based regimens
NMIBC treated with IL-15RαFc superagonist N-803 and BCG infusion
Challenges and perspective of cancer patients during the COVID-19 pandemic and the Lebanese financial crisis
Tailoring radiation therapy in the 21st century
Preventive oncology nutrition for healthy carriers and BRCA1/2 + breast cancer patients
Update: Cabozantinib plus nivolumab demonstrates continued survival benefit in aRCC
OncoAlert and ecancer weekly round up for February 7th - 13th, 2022
The global impact of the FDA's changing approval standards